The authors suggested that the two treatments had similar patient outcomes, with more intense therapy having slightly better outcomes.
This study examined the survival outcomes for patients treated with MAC or RIC..
63 patients were treated with MAC and 249 were treated with RIC.
Patients in the MAC group had a lower rate of relapse (46% of patients) than those treated with RIC (55% of patients).
The MAC group also had better rates of 2-year event-free survival (48%; no relapse, complication, or death) than patients in the RIC group (36%).